NANNING MAPLE LEAF PHARMACEUTI has a total of 26 patent applications. Its first patent ever was published in 1995. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and China. Its main competitors in its focus markets pharmaceuticals, chemical engineering and organic fine chemistry are SpineThera, DRUGRECURE APS and KOMINOX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 4 | |
#3 | China | 4 | |
#4 | United States | 4 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | United Kingdom | 2 | |
#7 | Brazil | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Chemical engineering | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Chemical or physical processes | |
#4 | Separation | |
#5 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kang Yuhong | 9 |
#2 | Shum Frank Hay Kong | 7 |
#3 | Zhou Maoqing | 7 |
#4 | Huang Xiaoyan | 5 |
#5 | Qiu Fanglong | 4 |
#6 | Pan Xinfu | 4 |
#7 | Zhang Xiao | 4 |
#8 | Shum Frank Haykong | 3 |
#9 | Shen Xiguang | 2 |
#10 | Yuhong Kang | 2 |
Publication | Filing date | Title |
---|---|---|
CN1568999A | Stable freeze dried formulation of spheroidine for medical use | |
US6559154B2 | Composition of sodium channel blocking compound | |
CN1354176A | Method for refining high-purity tetradoxin | |
CN1354177A | System for extracting tetradoxin with high yield | |
AU1888195A | The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence |